Tryptophan levels may explain why some migraine drugs fail
NCT ID NCT07177885
First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 27 times
Summary
This study aims to understand why over 20% of people with migraine don't get relief from triptan medications. Researchers will compare levels of tryptophan and related substances in the blood of people who respond well to triptans versus those who don't. The study involves 144 adults aged 18 to 50 with migraine. While participants may not benefit directly, the findings could lead to more personalized migraine treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.